# Provident Financial Services Inc: overview

PFS · NYSE · CIK 1178970 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfs.md) · [Financials](/companies/pfs/financials.md) · [Filings](/companies/pfs/filings.md) · [Insiders](/companies/pfs/insiders.md)

Latest reported revenue: [$19.6m](/filings/0001628280-26-054777.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 7, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-054777).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [17.9](/filings/0001628280-25-050020.md) | [16.5 d](/filings/0001628280-26-012814.md) | [18.9](/filings/0001628280-26-032754.md) | [18.3](/filings/0001628280-26-054777.md) | [17.7](/filings/0001628280-25-050020.md) | [18.0 d](/filings/0001628280-26-012814.md) | [20.6](/filings/0001628280-26-032754.md) | [19.6](/filings/0001628280-26-054777.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [260.0%](/filings/0001628280-25-050020.md) | [293.8% d](/filings/0001628280-26-012814.md) | [339.3%](/filings/0001628280-26-032754.md) | [393.8%](/filings/0001628280-26-054777.md) | [404.6%](/filings/0001628280-25-050020.md) | [463.6% d](/filings/0001628280-26-012814.md) | [385.4%](/filings/0001628280-26-032754.md) | [397.8%](/filings/0001628280-26-054777.md) |
| Diluted EPS | $ per share | [0.36](/filings/0001628280-25-050020.md) | not reported | [0.49](/filings/0001628280-26-032754.md) | [0.55](/filings/0001628280-26-054777.md) | [0.55](/filings/0001628280-25-050020.md) | not reported | [0.61](/filings/0001628280-26-032754.md) | [0.60](/filings/0001628280-26-054777.md) |
| Free cash flow | $m | [67.9 d](/filings/0001628280-25-050020.md) | [238 d](/filings/0001628280-26-012814.md) | [87.4](/filings/0001628280-26-032754.md) | [183 d](/filings/0001628280-26-054777.md) | [96.7 d](/filings/0001628280-25-050020.md) | [64.1 d](/filings/0001628280-26-012814.md) | [81.0](/filings/0001628280-26-032754.md) | [109 d](/filings/0001628280-26-054777.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [57.6](/filings/0001628280-24-007678.md) | [55.0](/filings/0001628280-25-008991.md) | [57.5](/filings/0001628280-26-012814.md) | [68.3](/filings/0001628280-26-012814.md) | [73.1](/filings/0001628280-26-012814.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [291.7%](/filings/0001628280-24-007678.md) | [319.4%](/filings/0001628280-25-008991.md) | [223.2%](/filings/0001628280-26-012814.md) | [169.2%](/filings/0001628280-26-012814.md) | [398.3%](/filings/0001628280-26-012814.md) |
| Diluted EPS | $ per share | [2.19](/filings/0001628280-24-007678.md) | [2.35](/filings/0001628280-25-008991.md) | [1.71](/filings/0001628280-26-012814.md) | [1.05](/filings/0001628280-26-012814.md) | [2.23](/filings/0001628280-26-012814.md) |
| Free cash flow | $m | [143](/filings/0001628280-24-007678.md) | [191](/filings/0001628280-25-008991.md) | [166](/filings/0001628280-26-012814.md) | [425](/filings/0001628280-26-012814.md) | [431](/filings/0001628280-26-012814.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pfs/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $454.9m | 19,244,342 |  | Reduced −78,760 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $194.6m | 8,233,317 |  | Added +168,607 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $193.2m | 8,173,769 |  | Added +103,035 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $190.2m | 8,044,048 |  | Added +762,432 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $133.4m | 5,644,266 |  | Added +35,332 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $101.4m | 4,291,092 |  | Added +704,900 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $82.6m | 3,492,733 |  | Added +171,226 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $73.3m | 3,101,027 |  | Reduced −2,685,628 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $54.3m | 2,296,256 |  | Added +2,254,968 |
| [SYSTEMATIC FINANCIAL MANAGEMENT LP](/funds/1085936.md) | 2026-06-30 | $44.3m | 1,871,847 |  | Reduced −84,901 |

## Recent filings

[All 1,521 filings](/companies/pfs/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 12:50 ET | [8-K](/filings/0001628280-26-068115.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-068115 |
| 2026-10-29 | 12:45 ET | [8-K](/filings/0001628280-26-068111.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-068111 |
| 2026-08-24 | 16:14 ET | [8-K](/filings/0001552781-26-000462.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001552781-26-000462 |
| 2026-08-14 | 08:32 ET | [8-K](/filings/0001628280-26-056950.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-056950 |
| 2026-08-07 | 15:07 ET | [10-Q](/filings/0001628280-26-054777.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054777 |
| 2026-08-04 | 17:27 ET | [8-K](/filings/0001628280-26-052747.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-052747 |
| 2026-07-30 | 16:50 ET | [8-K](/filings/0001628280-26-051122.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051122 |
| 2026-07-30 | 11:51 ET | [8-K](/filings/0001628280-26-050919.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-050919 |
| 2026-07-30 | 11:42 ET | [8-K](/filings/0001628280-26-050914.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-050914 |
| 2026-06-23 | 17:11 ET | [8-K](/filings/0001628280-26-044966.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-044966 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-012814.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/c39500ff-0031-4d0e-9f3f-55b461b9d465)

## About the filer

- CIK: 1178970
- Tickers: PFS
- Exchange: NYSE
- SIC code: 6035 Savings Institution, Federally Chartered
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 12:53 ET. No prices; not investment advice.